Nasopharyngeal Carcinoma
📧 Sign up to get email alerts when something new happens for Nasopharyngeal Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-02-13Clinical Trial Update: CDK4/6 Inhibitor Plus Camrelizumab for PD-1 Inhibitor Refractory R/M NPC [Phase 2]
Phase 2 clinical trial evaluating a CDK4/6 inhibitor in combination with camrelizumab for PD-1 inhibitor-refractory recurrent/metastatic nas…
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: Clinical Study of Mitoxantrone Hydrochloride Liposome Injection Combined With Capecitabine Versus Capecitabine Monotherapy in Patients With Recurrent Metastatic Nasopharyngeal Carcinoma Who Failed Platinum-containing Treatment [Phase 3]
Phase 3 trial evaluating mitoxantrone hydrochloride liposome injection plus capecitabine versus capecitabine alone in recurrent metastatic n…
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: Targeted or Chemotherapy Combined With Immunotherapy Versus Chemotherapy for PD-1 Inhibitor Refractory R/M NPC [Phase 2]
Phase 2 trial evaluating targeted or chemotherapy combined with immunotherapy versus chemotherapy for PD-1 inhibitor-refractory recurrent/me…
-
CLINICAL_TRIALS trial_result · 2023-02-06Clinical Trial Update: Toripalimab and Gemcitabine in Recurrent or Metastatic Nasopharyngeal Carcinoma. [Phase 2]
Phase 2 clinical trial evaluating toripalimab in combination with gemcitabine for recurrent or metastatic nasopharyngeal carcinoma.
-
CLINICAL_TRIALS trial_result · 2023-01-31Clinical Trial Update: Effect of Standard Nutrition Therapy on Nutritional Status and Prognosis in Locoregionally Advanced Nasopharyngeal Carcinoma Patients With Malnutrition [Phase 3]
Phase 3 trial evaluating the impact of standard nutrition therapy on nutritional status and prognosis in locoregionally advanced nasopharyng…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-01-13Clinical Trial Update: Apatinib Combined With PD-1 in the Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma [Phase 2]
A phase 2 clinical trial evaluating apatinib in combination with PD-1 inhibitor for recurrent or metastatic nasopharyngeal carcinoma has com…
-
CLINICAL_TRIALS trial_result · 2023-01-10Clinical Trial Update: Radiotherapy Alone Versus Concurrent Chemo-radiotherapy for Nasopharyngeal Carcincoma Patients With Undectable EBV DNA After One Cylce Neoadjuvant Chemotherpy [Phase 3]
A Phase 3 clinical trial comparing radiotherapy alone to concurrent chemoradiotherapy in nasopharyngeal carcinoma patients with detectable d…
-
CLINICAL_TRIALS trial_result · 2022-11-07Clinical Trial Update: Radiotherapy Plus Concurrent Nimotuzumab or Cisplatin in Stage II-III Nasopharyngeal Carcinoma [Phase 3]
Phase 3 trial evaluating radiotherapy with either nimotuzumab or cisplatin concurrently for stage II-III nasopharyngeal carcinoma; status no…
-
CLINICAL_TRIALS trial_result · 2022-10-28Clinical Trial Update: Maintenance Capecitabine Plus Best Supportive Care Versus Best Supportive Care for Metastatic Nasopharyngeal Carcinoma [Phase 3]
Phase 3 trial assessing maintenance capecitabine plus best supportive care versus best supportive care alone in metastatic nasopharyngeal ca…
-
CLINICAL_TRIALS trial_result · 2022-09-27Clinical Trial Update: Optimization of Cervical Nodal CTV for Early and Medium Stage NPC [Phase 3]
Phase 3 clinical trial update focusing on optimizing cervical nodal clinical target volume for early and medium stage nasopharyngeal carcino…
-
CLINICAL_TRIALS trial_result · 2022-09-19Clinical Trial Update: Elective Level Ib Irradiation in Nasopharyngeal Carcinoma Patients Based on the International Guidelines [Phase 3]
Phase 3 trial investigating elective level Ib irradiation in nasopharyngeal carcinoma following international guidelines.
-
CLINICAL_TRIALS trial_result · 2022-08-31Clinical Trial Update: Concurrent Cisplatin Chemoradiation With or Without Capecitabine as Adjuvant Chemotherapy in Local Advanced High Risk Nasopharyngeal Carcinoma: Randomized Control Clinical Trial [Phase 3]
Phase 3 randomized trial evaluating concurrent cisplatin chemoradiation with or without capecitabine as adjuvant therapy for local advanced …
-
CLINICAL_TRIALS trial_result · 2022-08-31Clinical Trial Update: Chemoradiotherapy Plus Anti-PD1 in Recurrent NPC: A Multicenter, Open-label, Randomised, Controlled, Phase III Trial [Phase 3]
A multicenter Phase 3 trial evaluating chemoradiotherapy plus anti-PD1 in recurrent nasopharyngeal carcinoma is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2022-08-17Clinical Trial Update: Induction Versus Adjuvant Gemcitabine/Cisplatin in Locally Advanced Non-metastatic Nasopharyngeal Carcinoma [Phase 3]
Phase 3 trial comparing induction versus adjuvant gemcitabine/cisplatin in locally advanced non-metastatic nasopharyngeal carcinoma is curre…
-
CLINICAL_TRIALS trial_result · 2022-07-08Clinical Trial Update: Neoadjuvant and Adjuvant Tislelizumab for Nasopharyngeal Carcinoma [Phase 2]
Phase 2 clinical trial update evaluating neoadjuvant and adjuvant tislelizumab for nasopharyngeal carcinoma.
-
CLINICAL_TRIALS trial_result · 2022-07-06Clinical Trial Update: Chemotherapy Plus Subsequent Loco-regional Radiotherapy Combined With Toripalimab in the De Novo Metastatic Nasopharyngeal Carcinoma [Phase 2]
Phase 2 trial evaluating chemotherapy plus loco-regional radiotherapy with toripalimab for de novo metastatic nasopharyngeal carcinoma.
-
CLINICAL_TRIALS trial_result · 2022-07-01Clinical Trial Update: Phase III Study of Camrelizumab in Combination With Chemotherapy in Recurrent/Metastatic Nasopharyngeal Carcinoma [Phase 3]
A Phase III trial evaluating camrelizumab in combination with chemotherapy for recurrent/metastatic nasopharyngeal carcinoma.
-
CLINICAL_TRIALS trial_result · 2022-06-27Clinical Trial Update: A Two-blinded, Multicentre, Phase II/III RCT of Concurrent Chemo-radiotherapy Combined or Not Combined With TNF as the Therapy for LA-NPC [Phase 2, Phase 3]
Phase II/III randomized trial evaluating concurrent chemoradiotherapy with or without TNF for nasopharyngeal carcinoma is not yet recruiting…
-
CLINICAL_TRIALS trial_result · 2022-06-14Clinical Trial Update: Sintilimab Combined With Chemotherapy and Radiotherapy in Newly Diagnosed Metastatic Nasopharyngeal Carcinoma: A Multicenter Study [Phase 2]
Phase 2 trial evaluating sintilimab with chemotherapy and radiotherapy in newly diagnosed metastatic nasopharyngeal carcinoma.
-
CLINICAL_TRIALS trial_result · 2022-06-07Clinical Trial Update: Fluzoparib and Camrelizumab in Treating Patients With R/M NPC That Progressed After First-line Chemotherapy [Phase 2]
Phase 2 trial evaluating the combination of fluzoparib and camrelizumab in nasopharyngeal carcinoma that progressed after first-line chemoth…
-
CLINICAL_TRIALS trial_result · 2022-05-10Clinical Trial Update: Nedaplatin Versus Cisplatin in Treatment for Nasopharyngeal Carcinoma [Phase 3]
Phase 3 trial comparing nedaplatin with cisplatin for nasopharyngeal carcinoma; currently recruiting.
-
CLINICAL_TRIALS trial_result · 2022-05-10Clinical Trial Update: Nedaplatin in Treatment for Nasopharyngeal Carcinoma [Phase 2]
Phase 2 clinical trial update for nedaplatin in treating nasopharyngeal carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2022-05-06Clinical Trial Update: Adjuvant Sintilimab Plus Capecitabine in Nasopharyngeal Carcinoma [Phase 2]
Phase 2 trial update investigating adjuvant sintilimab plus capecitabine in nasopharyngeal carcinoma.
-
CLINICAL_TRIALS trial_result · 2022-04-29Clinical Trial Update: Carbon-Ion Radiotherapy Plus Camrelizumab for Locally Recurrent Nasopharyngeal Carcinoma [Phase 2]
Phase 2 trial evaluating carbon-ion radiotherapy plus camrelizumab for locally recurrent nasopharyngeal carcinoma.
-
CLINICAL_TRIALS trial_result · 2022-04-29Clinical Trial Update: IMRT Combined With Toripalimab in Unresectable Locally Recurrent Nasopharyngeal Carcinoma. [Phase 2]
Phase 2 clinical trial evaluating intensity-modulated radiotherapy (IMRT) combined with toripalimab in unresectable locally recurrent nasoph…